The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia

Fertility and Sterility

Volumn 88, Issue 4, 2007, Pages 847-853

  Farmakiotis, Dimitrios ^a   Farmakis, Christos ^a   Rousso, David ^a   Kourtis, Anargyros ^a   Katsikis, Ilias ^a   Panidis, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

male infertility; oligozoospermia; SERM; Toremifene

Indexed keywords

FOLLITROPIN; GONADOTROPIN; INHIBIN B; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TOREMIFENE;

ADULT; ARTICLE; CELL STRUCTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EXOCRINE SECRETION; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN RELEASE; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IDIOPATHIC DISEASE; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT PARAMETERS; OLIGOSPERMIA; OUTCOME ASSESSMENT; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEMEN ANALYSIS; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; SUBFERTILITY; TESTIS; TESTOSTERONE BLOOD LEVEL; UNIVERSITY HOSPITAL;

ADULT; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INHIBINS; MALE; MIDDLE AGED; OLIGOSPERMIA; PREGNANCY; PREGNANCY RATE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEMEN; SEX HORMONE-BINDING GLOBULIN; SPERM MOTILITY; SPERMATOZOA; TESTIS; TESTOSTERONE; TOREMIFENE;

EID: 34848918184     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.12.038     Document Type: Article

References (23)

1. Plouffe Jr. L., and Siddhanti S. The effect of selective estrogen receptor modulators on parameters of the hypothalamic-pituitary-gonadal axis. Ann NY Acad Sci 949 (2001) 251-258
2. Plouffe Jr. L. Selective estrogen receptor modulators (SERMs) in clinical practice. J Soc Gynecol Investig 7 (2000) S38-S46
3. Riggs B.L., and Hartmann L.C. Selective estrogen receptor modulators. Mechanisms of action and application to clinical practice. N Eng J Med 348 (2003) 618-629
4. Adashi E.Y. Ovulation induction: clomiphene citrate. In: Adashi E.Y., and Rosenwaks J.A. (Eds). Reproductive endocrinology, surgery, and technology (1996), Lippincott-Raven, Philadelphia 1181-1206
5. Comhaire F. Treatment of oligozoospermia with tamoxifen. Int J Fertil 21 (1976) 232-238
6. Buvat J., Ardaens K., Lemaire A., Gauthier A., Gasnault J.P., and Buvat-Herbaut M. Increased sperm count in 25 cases of idiopathic normozoospermic oligospermia following treatment with tamoxifen. Fertil Steril 39 (1983) 700-703
7. Kotoulas I.G., Cardamakis E., Michopoulos J., Mitropoulos D., and Dounis A. Tamoxifen treatment in male infertility. I. Effect on spermatozoa. Fertil Steril 61 (1994) 911-914
8. Comhaire F., Milingos S., Liapi A., Gordts S., Campo R., Depypere H., et al. The effective cumulative pregnancy rate of different modes of treatment of male infertility. Andrologia 27 (1995) 217-221
9. Comhaire F., Zalata A., and Mahmoud A. Critical evaluation of the effectiveness of different modes of treatment of male infertility. Andrologia 28 (1996) 31-35
10. Adamopoulos D.A., Nicopoulou S., Kapolla N., Karamertzanis M., and Andreou E. The combination of testosterone undecanoate with tamoxifen citrate enhances the effect of each agent given independently on seminal parameters in men with idiopathic oligozoospermia. Fertil Steril 67 (1997) 756-762
11. Adamopoulos D., Pappa A., Billa E., Nicopoulou S., Koukkou E., and Michopoulos J. Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia. Fertil Steril 80 (2003) 914-920
12. Rowe P., Comhaire F., Hargreave T., and Mahmoud A. WHO manual for the standardized investigation, diagnosis and management of the infertile male (2000), Cambridge University Press, Cambridge, UK 37-60
13. Kalahanis J., Rousso D., Kourtis A., Mavromatidis G., Makedos G., and Panidis D. Round-headed spermatozoa in semen specimens from fertile and subfertile men. J Reprod Med 47 (2002) 489-493
14. Rousso D., Kourtis A., Mavromatidis G., Gkoutzioulis F., Makedos G., and Panidis D. Pyriform head: a frequent but little-studied morphological abnormality of sperm. Arch Androl 48 (2002) 267-272
15. Panidis D., Rousso D., Matalliotakis I., Kourtis A., Mavromatidis G., Mamopoulos M., and Koumantakis E. Do characteristic spermatozoal morphological abnormalities exist in patients who have undergone unilateral orchiectomy and preventive radiotherapy?. Int J Fertil Women Med 48 (2003) 83-87
16. Makler A. The improved ten-micrometer chamber for rapid sperm count and motility evaluation. Fertil Steril 33 (1980) 155-161
17. Panidis D., Matalliotakis I., Skiadopoulos S., Rousso D., Koumantakis E., and Mamopoulos M. The sperm deformity and multiple anomalies indices: are they reliable in the identification of fertile and infertile semen?. Int J Fertil Women Med 43 (1998) 159-164
18. Kangas L. Review of the pharmacological properties of toremifene. J Steroid Biochem 36 (1990) 191-195
19. Labrie F., Labrie C., Belanger A., Simard J., Gauthier S., Luu-The V., et al. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. J Steroid Biochem Mol Biol 69 (1999) 51-84
20. Zalaka A., Hafez T., Verdonck L., Vermoulen L., and Comhaire F. Androgens in seminal plasma: markers of the surface epithelium on the male genital tract. Int J Androl 18 (1995) 271-277
21. Smals A.G.H., Pieters G.F.M., and Drayer J.I.M. Tamoxifen suppresses gonadotropin-induced 16-alpha-hydroxy-progesterone accumulation in normal men. J Clin Endocrinol Metab 51 (1980) 1026-1029
22. de Ronde W., van der Schouw Y.T., Muller M., Grobbee D.E., Gooren L.J., Pols H.A., and de Jong F.H. Associations of sex-hormone-binding globulin (SHBG) with non-SHBG-bound levels of testosterone and estradiol in independently living men. J Clin Endocrinol Metab 90 (2005) 157-162
23. Duschek E.J., Gooren L.J., and Netelenbos C. Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men. Eur J Endocrinol 150 (2004) 539-546